The World Health Organization (WHO) has recommended a new malaria vaccine that is expected to be rolled out early next year. The vaccine, developed by researchers at the University of Oxford, has shown high efficacy and can be scaled up for widespread use. It is specifically designed to protect children against the parasite-borne disease. The WHO's endorsement of the vaccine is seen as a significant step in the fight against malaria, which kills hundreds of thousands of people each year, particularly children. The vaccine is cheaper and easier to produce compared to its predecessor. The recommendation by the WHO paves the way for the global roll-out of the vaccine, which is expected to have a major impact in reducing the burden of malaria in endemic areas.